Composition of trans-dominant variants of viral proteins for obtaining an anti-viral effect

摘要

A composition resulting from a combination of trans-dominant variants of two viral proteins TAT and REV from HIV, and the use thereof as a combination product are disclosed. A vector for expressing the two variants, a eukaryotic cell containing the same, and a pharmaceutical composition for treating viral infections, are also disclosed.